DCGI grants conditional market approval for Covaxin, Covishield

Jan 27, 2022

New Delhi [India], January 27 : The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin...

SEC recommends regular market approval to Covaxin, Covishield for adults

Jan 19, 2022

New Delhi [India], January 19 : The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to...

Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

Jan 26, 2022

New Delhi [India], January 26 : The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is...

SEC asks for more data to grant full market approval to Covaxin and Covishield

Jan 14, 2022

New Delhi [India], January 14 : The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted...

Afghanistan hails emergency use approval to Covishield

Jan 03, 2021

New Delhi [India], January 3 : Tahir Qadiry, Afghan Charge d'Affaires on Sunday hailed India's decision to grant emergency use to Serum Institute of...

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

Jan 14, 2022

New Delhi [India], January 14 : Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute...